Accueil/Actions/TWST

TWST

USD

Twist Bioscience Corporation Common Stock

$30.060-0.970 (-3.126%)

Prix en Temps Réel

Healthcare

Diagnostics & Research

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$31.030

Haut

$31.390

Bas

$29.715

Volume

1.91M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.8B

Industrie

Diagnostics & Research

Pays

United States

Statistiques de Trading

Volume Moyen

1.74M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $24.07Actuel $30.060Haut $55.33

Actualités Connexes

4 nov. 2025 · 13:04

Analyst Upgrades

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

Stephens & Co. analyst Steven Etoch initiates coverage on Twist Bioscience with a Overweight rating and announces Price Target of $41.

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

4 nov. 2025 · 13:00

BusinessWire

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

3 nov. 2025 · 13:00

BusinessWire

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ:TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that it has granted a total of